Use of immunosuppression and subsequent cancer incidence: cohort study

Autor: Naira Khachatryan, Gui-Shuang Ying, James T Rosenbaum, Gary N Holland, Maxwell Pistilli, John H. Kempen, Nisha R Acharya, Debra A Goldstein, John H Kempen, Ebenezer Daniel, Jennifer E Thorne, Careen Y Lowder, Teresa L Liesegang, Eric B Suhler, Grace A Levy-Clarke, Robert B Nussenblatt, Tracy Giles, RUSSELL W READ, Yannek I Leiderman, Craig W Newcomb, Nirali P Bhatt, James P Dunn, Asaf Hanish, Kathy J Helzlsouer, Siddharth S Pujari, Teresa Liesegang, Lucia Sobrin, Hosne Begum, Pichaporn Artornsombudh, Jeanine M Buchanich, Terri L Washington, Charles Stephen Foster, Douglas Alan Jabs, Hatice Nida Sen, Kurt A Dreger, Hosne A Begum, Tonetta D Fitzgerald, Srishti Kothari, Abhishek R Payal, Sapna S Gangaputra, Roje Oktay Kaçmaz, Armin Maghsoudlou, Hilkiah K Suga, Clara M Pak, Hilkiah K. Suga, John Caccaviello, C. Stephen Foster, R. Oktay Kaçmaz, Siddharth S. Pujari, Abhishek Payal, Jennifer E. Thorne, Douglas A. Jabs, Kurt A. Dreger, James P. Dunn, Sapna S. Gangaputra, Eric B. Suhler, James T. Rosenbaum, H. Nida Sen, Grace A. Levy-Clarke, Robert B. Nussenblatt, Nirali P. Bhatt, Tonetta D. Fitzgerald, Kathy J. Helzlsouer, Marshall M. Joffe, Jeanine M. Buchanich, Terri L. Washington, Careen Y. Lowder, Gary N. Holland, Nisha R. Acharya, Yannek I. Liederman, Jie Debra A. Goldstein, Debra A. Goldstein, Jie (Jessica) Sun, Russell W. Read, Glenn J. Jaffe, Paul A. Latkany, Janet L. Davis, Sunir J. Garg

Publikováno v: BMJ Oncology, Vol 2, Iss 1 (2023)

Objective Evaluate the association between cancer incidence and immunosuppressive treatment in patients with ocular inflammatory disease (OID).Methods and analysis We performed a retrospective cohort study of patients from 10 US OID subspecialty prac

Externí odkaz: https://doaj.org/article/7f7b05e8b97f47209c76fd28322a5d71